共查询到20条相似文献,搜索用时 15 毫秒
1.
Dr. Francesco A. Greco Dr. Elisa Albini Dr. Alice Coletti Dr. Daniela Dolciami Prof. Andrea Carotti Dr. Ciriana Orabona Prof. Ursula Grohmann Prof. Antonio Macchiarulo 《ChemMedChem》2019,14(24):2084-2092
Indoleamine 2,3-dioxygenase 1 (IDO1) catalyzes the oxidative cleavage of l -Tryptophan (l -Trp) to yield N-formyl-kynurenine in the first and rate limiting step of the kynurenine pathway. Bioactive metabolites, involved in the regulation of important immunological responses and neurological processes, are then produced by downstream enzymes along the pathway. Inhibitors of IDO1 are being designed and developed as therapeutic agents for immuno-oncology. In this work, we investigated the molecular recognition path of l -Trp to IDO1, integrating biophysical methods with supervised molecular dynamics (suMD) and mutagenesis experiments. Results allowed disclosing for the first time high and low dissociation constants of l -Trp to IDO1, and the presence of a metastable interaction site located at the upper part of a channel whose borders are defined by the EF-loop and the C-terminal part of the JK-loop. Collectively, our results provide new clues for the design of next-generation IDO1 ligands. 相似文献
2.
Guanyou Huang Yaoying Zeng Peiyan Liang Congrong Zhou Shuyun Zhao Xiuyan Huang Lingfei Wu Xianhui He 《International journal of molecular sciences》2012,13(9):10863-10879
Indoleamine 2,3-dioxygenase (IDO) has been implicated in preventing the fetus from undergoing maternal T cell-mediated immune responses, yet the mechanism underlying these kinds of IDO-mediated immune responses has not been fully elucidated. Since the CD4 molecule plays a central role in the onset and regulation of antigen-specific immune responses, and T cell is sensitive in the absence of tryptophan, we hypothesize that IDO may reduce cell surface CD4 expression. To test this hypothesis, an adenoviral vector-based construct IDO-EGFP was generated and the effect of IDO-EGFP on CD4 expression was determined on recombinant adenoviral infected C8166 and MT-2 cells, by flow cytometry and/or Western blot analysis. The results revealed a significant downregulation of cell membrane CD4 in pAd-IDOEGFP infected cells when compared to that of mock-infected cells or infection with empty vector pAd-EGFP. Further experiments disclosed that either an addition of tryptophan or IDO inhibitor could partly restore CD4 expression in pAd-IDOEGFP infected C8166 cells. Our findings suggest that downregulation of CD4 by IDO might be one of the mechanisms through which IDO regulates T cell-mediated immune responses. 相似文献
3.
Daojing Yan Jiakun Xu Xiang Wang Jiaxing Zhang Gang Zhao Yingwu Lin Xiangshi Tan 《International journal of molecular sciences》2022,23(9)
Indoleamine 2,3-dioxygenase 1 (IDO1) is an attractive heme enzyme for its significant function in cancer immunotherapy. Potent IDO1 inhibitors have been discovered for decades, whereas no clinical drugs are used for cancer treatment up to now. With the goal of developing medically valuable IDO inhibitors, we performed a systematic study of SAR405838 analogs with a spiro-oxindole skeleton in this study. Based on the expression and purification of human IDO1, the inhibitory activity of spiro-oxindole skeleton compounds to IDO1 was evaluated by IC50 and Ki values. The results demonstrated that inhibitor 3 exhibited the highest IDO1 inhibitory activity with IC50 at 7.9 μM among all inhibitors, which is ~six-fold of the positive control (4−PI). Moreover, inhibitor 3 was found to have the most effective inhibition of IDO1 in MCF-7 cancer cells without toxic effects. Molecular docking analysis revealed that the hydrophobic interaction stabilized the binding of inhibitor 3 to the IDO1 active site and made an explanation for the uncompetitive mode of inhibitors. Therefore, this study provides valuable insights into the screen of more potent IDO1 inhibitors for cancer immunotherapy. 相似文献
4.
Yuriko Tanaka Mayu Onozato Tetuo Mikami Terumi Kohwi-Shigematsu Takeshi Fukushima Motonari Kondo 《International journal of molecular sciences》2021,22(18)
Sjögren’s syndrome (SS) is a chronic autoimmune disease characterized by dysfunction of salivary and lacrimal glands, resulting in xerostomia (dry mouth) and keratoconjunctivitis sicca (dry eyes). Autoantibodies, such as anti-SSA and anti-SSB antibodies, are hallmarks and important diagnostic factors for SS. In our previous study, we demonstrated that SS-like xerostomia was observed in SATB1 conditional knockout (SATB1cKO) mice, in which the floxed SATB1 gene was specifically deleted in hematopoietic cells as early as 4 weeks of age. In these mice, autoantibodies were not detected until 8 weeks of age in SATB1cKO mice, although exocrine gland function reached its lowest at this age. Therefore, other markers may be necessary for the diagnosis of SS in the early phase. Here, we found that mRNA expression of the interferon γ (IFN-γ) gene and the IFN-responsive indoleamine 2,3-dioxygenase (IDO) gene is upregulated in the salivary glands of SATB1cKO mice after 3 and 4 weeks of age, respectively. We detected l-kynurenine (l-KYN), an intermediate of l-tryptophan (l-Trp) metabolism mediated by IDO, in the serum of SATB1cKO mice after 4 weeks of age. In addition, the upregulation of IDO expression was significantly suppressed by the administration of IFN-γ neutralizing antibodies in SATB1cKO mice. These results suggest that the induction of IFN-dependent IDO expression is an initial event that occurs immediately after the onset of SS in SATB1cKO mice. These results also imply that serum l-KYN could be used as a marker for SS diagnosis in the early phases of the disease before autoantibodies are detectable. 相似文献
5.
Yong Zheng Paul M. Stafford Kurt R. Stover Darapaneni Chandra Mohan Mayuri Gupta Eric C. Keske Paolo Schiavini Laura Villar Fan Wu Alexander Kreft Kiersten Thomas Elana Raaphorst Jagadeesh P. Pasangulapati Siva R. Alla Simmi Sharma Ramana R. Mittapalli Irina Sagamanova Shea L. Johnson Mark A. Reed Donald F. Weaver 《ChemMedChem》2021,16(14):2195-2205
Indoleamine 2,3-dioxygenase 1 (IDO1) is a promising therapeutic target in cancer immunotherapy and neurological disease. Thus, searching for highly active inhibitors for use in human cancers is now a focus of widespread research and development efforts. In this study, we report the structure-based design of 2-(5-imidazolyl)indole derivatives, a series of novel IDO1 inhibitors which have been designed and synthesized based on our previous study using N1-substituted 5-indoleimidazoles. Among these, we have identified one with a strong IDO1 inhibitory activity (IC50=0.16 μM, EC50=0.3 μM). Structural-activity relationship (SAR) and computational docking simulations suggest that a hydroxyl group favorably interacts with a proximal Ser167 residue in Pocket A, improving IDO1 inhibitory potency. The brain penetrance of potent compounds was estimated by calculation of the Blood Brain Barrier (BBB) Score and Brain Exposure Efficiency (BEE) Score. Many compounds had favorable scores and the two most promising compounds were advanced to a pharmacokinetic study which demonstrated that both compounds were brain penetrant. We have thus discovered a flexible scaffold for brain penetrant IDO1 inhibitors, exemplified by several potent, brain penetrant, agents. With this promising scaffold, we provide herein a basis for further development of brain penetrant IDO1 inhibitors. 相似文献
6.
hIDO1 is a heme−dioxygenase overexpressed in the tumor microenvironment and is implicated in the survival of cancer cells. Metabolism of tryptophan to N-formyl−kynurenine by hIDO1 leads to immune suppression to result in cancer cell immune escape. In this article, we discuss the discovery of selective hIDO1 inhibitors for therapeutic intervention that have been promoted to clinical trials and for which crystallographic structural information is available for the respective inhibitor−enzyme complex. The structural insights are based on the complex crystal structures and the relative biological data profiles. The structural basis of selective hIDO1 inhibition, as discussed herein, opens new avenues to the discovery of novel inhibitors with improved activity profiles, selectivity, and distinct structure frameworks. 相似文献
7.
Dr. Sarah S. Henrikus Konstantinos Tassis Dr. Lei Zhang Dr. Jasper H. M. van der Velde Christian Gebhardt Prof. Andreas Herrmann Prof. Gregor Jung Prof. Dr. Thorben Cordes 《Chembiochem : a European journal of chemical biology》2021,22(23):3283-3291
Genetically encodable fluorescent proteins have revolutionized biological imaging in vivo and in vitro. Despite their importance, their photophysical properties, i. e., brightness, count-rate and photostability, are relatively poor compared to synthetic organic fluorophores or quantum dots. Intramolecular photostabilizers were recently rediscovered as an effective approach to improve photophysical properties of organic fluorophores. Here, direct conjugation of triplet-state quenchers or redox-active substances creates high local concentrations of photostabilizer around the fluorophore. In this paper, we screen for effects of covalently linked photostabilizers on fluorescent proteins. We produced a double cysteine mutant (A206C/L221C) of α-GFP for attachment of photostabilizer-maleimides on the β-barrel near the chromophore. Whereas labelling with photostabilizers such as trolox, a nitrophenyl group, and cyclooctatetraene, which are often used for organic fluorophores, had no effect on α-GFP-photostability, a substantial increase of photostability was found upon conjugation to azobenzene. Although the mechanism of the photostabilizing effects remains to be elucidated, we speculate that the higher triplet-energy of azobenzene might be crucial for triplet-quenching of fluorophores in the blue spectral range. Our study paves the way for the development of fluorescent proteins with photostabilizers in the protein barrel by methods such as unnatural amino acid incorporation. 相似文献
8.
Tyler Eck Mariana Laureano de Souza Melvin Delvillar Kutub Ashraf Rammohan R. Yadav Bheemanaboina Ramappa Chakrasali Tamara Kreiss John J. Siekierka David P. Rotella Purnima Bhanot Nina M. Goodey 《Chembiochem : a European journal of chemical biology》2022,23(7):e202100704
Plasmodium falciparum cGMP-dependent protein kinase (PfPKG) is an enticing antimalarial drug target. Novel chemotypes are needed because existing inhibitors have safety issues that may prevent further development. This work demonstrates isoxazole-based compounds are potent ATP competitive inhibitors of PfPKG and discloses a new analogue in this series. Isoxazoles 3 and 5 had Ki values that are comparable to a known standard, 4-[2-(4-fluorophenyl)-5-(1-methylpiperidine-4-yl)-1H pyrrol-3-yl] pyridine. They also exhibited excellent selectivity for PfPKG over the human orthologue and the gatekeeper mutant T618Q PfPKG, which mimics the less accessible binding site of the human orthologue. The human orthologue's larger binding site volume is predicted to explain the selectivity of the inhibitors for the P. falciparum enzyme. 相似文献
9.
Michele Bellucci Andrea Pompa Carine De Marcos Lousa Eleonora Panfili Elena Orecchini Elisa Maricchiolo Daniele Fraternale Ciriana Orabona Francesca De Marchis Maria Teresa Pallotta 《International journal of molecular sciences》2021,22(10)
Genetic engineering of plants has turned out to be an attractive approach to produce various secondary metabolites. Here, we attempted to produce kynurenine, a health-promoting metabolite, in plants of Nicotiana tabacum (tobacco) transformed by Agrobacterium tumefaciens with the gene, coding for human indoleamine 2,3-dioxygenase 1 (IDO1), an enzyme responsible for the kynurenine production because of tryptophan degradation. The presence of IDO1 gene in transgenic plants was confirmed by PCR, but the protein failed to be detected. To confer higher stability to the heterologous human IDO1 protein and to provide a more sensitive method to detect the protein of interest, we cloned a gene construct coding for IDO1-GFP. Analysis of transiently transfected tobacco protoplasts demonstrated that the IDO1-GFP gene led to the expression of a detectable protein and to the production of kynurenine in the protoplast medium. Interestingly, the intracellular localisation of human IDO1 in plant cells is similar to that found in mammal cells, mainly in cytosol, but in early endosomes as well. To the best of our knowledge, this is the first report on the expression of human IDO1 enzyme capable of secreting kynurenines in plant cells. 相似文献
10.
Kelton A. Schleyer Ben Fetrow Peter Zannes Fatland Dr. Jun Liu Maya Chaaban Prof. Biwu Ma Prof. Lina Cui 《ChemMedChem》2021,16(7):1082-1087
Cathepsin L (CTL) is a cysteine protease demonstrating upregulated activity in many disease states. Overlapping substrate specificity makes selective detection of CTL activity difficult to parse from that of its close homologue CTV and the ubiquitous CTB. Current probes of CTL activity have limited applications due to either poor contrast or extra assay steps required to achieve selectivity. We have developed a fluorogenic probe, CTLAP, that displays good selectivity for CTL over CTB and CTV while exhibiting low background fluorescence attributed to dual quenching mechanisms. CTLAP achieves optimum CTL selectivity in the first 10 min of incubation, thus suggesting that it is amenable for rapid detection of CTL, even in the presence of competing cathepsins. 相似文献
11.
Dr. Guido V. Janssen Susan Zhang Dr. Remco Merkx Dr. Christa Schiesswohl Dr. Champak Chatterjee Prof. Dr. K. Heran Darwin Dr. Paul P. Geurink Dr. Gerbrand J. van der Heden van Noort Prof. Dr. Huib Ovaa 《Chembiochem : a European journal of chemical biology》2021,22(21):3082-3089
Tuberculosis is a global health problem caused by infection with the Mycobacterium tuberculosis (Mtb) bacteria. Although antibiotic treatment has dramatically reduced the impact of tuberculosis on the population, the existence and spreading of drug resistant strains urgently demands the development of new drugs that target Mtb in a different manner than currently used antibiotics. The prokaryotic ubiquitin-like protein (Pup) proteasome system is an attractive target for new drug development as it is unique to Mtb and related bacterial genera. Using a Pup-based fluorogenic substrate, we screened for inhibitors of Dop, the Mtb depupylating protease, and identified I-OMe-Tyrphostin AG538 ( 1 ) and Tyrphostin AG538 ( 2 ). The hits were validated and determined to be fast-reversible, non-ATP competitive inhibitors. We synthesized >25 analogs of 1 and 2 and show that several of the synthesized compounds also inhibit the depupylation actions of Dop on native substrate, FabD-Pup. Importantly, the pupylation activity of PafA, the sole Pup ligase in Mtb, was also inhibited by some of these compounds. 相似文献
12.
13.
以1,10-菲咯啉为原料经过三步反应合成得到5,6-二胺-1,10-菲咯啉,常温下5,6-二胺-1,10-菲咯啉与苯偶酰反应生成目标产物2,3-二苯基吡嗪[2,3-f][1,10]菲咯啉,并通过红外、核磁图对其进行了表征。 相似文献
14.
Daniel Herp Johannes Ridinger Dina Robaa Stephen A. Shinsky Karin Schmidtkunz Talha Z. Yesiloglu Theresa Bayer Raphael R. Steimbach Corey J. Herbst-Gervasoni Annika Merz Christophe Romier Peter Sehr Nikolas Gunkel Aubry K. Miller David W. Christianson Ina Oehme Wolfgang Sippl Manfred Jung 《Chembiochem : a European journal of chemical biology》2022,23(14):e202200180
Histone deacetylases (HDACs) are important epigenetic regulators involved in many diseases, especially cancer. Five HDAC inhibitors have been approved for anticancer therapy and many are in clinical trials. Among the 11 zinc-dependent HDACs, HDAC10 has received relatively little attention by drug discovery campaigns, despite its involvement, e. g., in the pathogenesis of neuroblastoma. This is due in part to a lack of robust enzymatic conversion assays. In contrast to the protein lysine deacetylase and deacylase activity of most other HDAC subtypes, it has recently been shown that HDAC10 has strong preferences for deacetylation of oligoamine substrates like acetyl-putrescine or -spermidine. Hence, it is also termed a polyamine deacetylase (PDAC). Here, we present the first fluorescent enzymatic conversion assay for HDAC10 using an aminocoumarin-labelled acetyl-spermidine derivative to measure its PDAC activity, which is suitable for high-throughput screening. Using this assay, we identified potent inhibitors of HDAC10-mediated spermidine deacetylation in vitro. Based on the oligoamine preference of HDAC10, we also designed inhibitors with a basic moiety in appropriate distance to the zinc binding hydroxamate that showed potent inhibition of HDAC10 with high selectivity, and we solved a HDAC10-inhibitor structure using X-ray crystallography. We could demonstrate selective cellular target engagement for HDAC10 but a lysosomal phenotype in neuroblastoma cells that was previously associated with HDAC10 inhibition was not observed. Thus, we have developed new chemical probes for HDAC10 that allow further clarification of the biological role of this enzyme. 相似文献
15.
Andr J. Niestroj Clemens Bruhn Martin E. Maier 《Advanced Synthesis \u0026amp; Catalysis》1998,340(2):175-177
Bromination of the disubstituted 4,5-dimethyl-1,3-cyclohexanedione ( 6 ) followed by oxidation of the resulting 3-bromo-5,6-dimethyl-2-cyclohexen-1-ones ( 7 ) gave 5-bromo-2,3-dimethylphenol ( 1 ) together with its constitutional isomer 3 . The structure of 1 was secured by a x-ray analysis of its tosyl derivative 8 . 相似文献
16.
17.
Dr. Mathew Sutherland Alice Li Anissa Kaghad Dimitrios Panagopoulos Dr. Fengling Li Dr. Magdalena Szewczyk Dr. David Smil Dr. Cora Scholten Dr. Léa Bouché Dr. Timo Stellfeld Dr. Cheryl H. Arrowsmith Dr. Dalia Barsyte Dr. Masoud Vedadi Dr. Ingo V. Hartung Dr. Holger Steuber Dr. Robert Britton Dr. Vijayaratnam Santhakumar 《ChemMedChem》2021,16(7):1116-1125
Protein arginine N-methyl transferase 4 (PRMT4) asymmetrically dimethylates the arginine residues of histone H3 and nonhistone proteins. The overexpression of PRMT4 in several cancers has stimulated interest in the discovery of inhibitors as biological tools and, potentially, therapeutics. Although several PRMT4 inhibitors have been reported, most display poor selectivity against other members of the PRMT family of methyl transferases. Herein, we report the structure-based design of a new class of alanine-containing 3-arylindoles as potent and selective PRMT4 inhibitors, and describe key structure–activity relationships for this class of compounds. 相似文献
18.
19.
利用高碘酸钠选择性氧化微晶纤维素,制备了氧化度(DO)为1.588的2,3-二醛基纤维素(DAC)。醛基在一定条件下可转换为羟基,本研究以硼氢化钠为还原剂,采用Box-Behnken方法对研究的变量进行响应曲面建模,以反应时间、固液比、反应温度为变量,以产物还原2,3-二醛基纤维素(R-DAC)的DO为因变量,优化R-DAC的制备条件。ANOVA证实了数学模型的充分性。结果表明:在优化条件下,可制备氧化度接近于0的R-DAC。采用红外光谱、同步热分析仪、X射线衍射仪等对R-DAC的结构、热稳定性、结晶性等进行了表征。 相似文献
20.
Yashwant Kumar Reman Kumar Singh Amrita Brajagopal Hazra 《Chembiochem : a European journal of chemical biology》2021,22(24):3414-3424
Flavins play a central role in metabolism as molecules that catalyze a wide range of redox reactions in living organisms. Several variations in flavin biosynthesis exist among the domains of life, and their analysis has revealed many new structural and mechanistic insights till date. The cytidine triphosphate (CTP)-dependent riboflavin kinase in archaea is one such example. Unlike most kinases that use adenosine triphosphate, archaeal riboflavin kinases utilize CTP to phosphorylate riboflavin and produce flavin mononucleotide. In this study, we present the characterization of a new mesophilic archaeal CTP-utilizing riboflavin kinase homologue from Methanococcus maripaludis (MmpRibK), which is linked closely in sequence to the previously characterized thermophilic Methanocaldococcus jannaschii homologue. We reconstitute the activity of MmpRibK, determine its kinetic parameters and molecular factors that contribute to its unique properties, and finally establish the residues that improve its thermostability using computation and a series of experiments. Our work advances the molecular understanding of flavin biosynthesis in archaea by the characterization of the first mesophilic CTP-dependent riboflavin kinase. Finally, it validates the role of salt bridges and rigidifying amino acid residues in imparting thermostability to this unique structural fold that characterizes archaeal riboflavin kinase enzymes, with implications in enzyme engineering and biotechnological applications. 相似文献